60 Degrees Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of 60 Degrees Pharmaceuticals generated cash of -$4,542,910, which is less than the previous year. Cash used in financing activities reached the amount of $6,474,565 last year. Net change in cash is therefore $1,877,620.
Cash Flow
| 2020 | -167.29K | -70.97K | 277.35K |
|---|---|---|---|
| 2021 | -649.10K | -35.39K | 611.22K |
| 2022 | -1.00M | -60.13K | 1.22M |
| 2023 | -4.54M | -115.88K | 6.47M |
SXTP Cash Flow Statement (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Cash at beginning of period | 264.86K | 115.39K | 191.70K | 286.87K |
Operating activities | ||||
Net income | -3.81M | -6.17M | -4.26M | -3.04M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 100.37K | 78.78K | 71.78K | 27.86K |
Stock-based compensation expense | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 0 | 100.39K | 713.06K | -660.27K |
Inventories | 212.74K | -52.93K | 312.22K | 190.77K |
Accounts payable | -214.73K | 169.99K | -844.67K | 796.29K |
Cash generated by operating activities | -4.54M | -1.00M | -649.10K | -167.29K |
Investing activities | ||||
Purchases Of Investments | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -57.62K | -60.13K | -35.39K | -70.97K |
Acquisitions Net | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -115.88K | -60.13K | -35.39K | -70.97K |
Financing activities | ||||
Common Stock Issued | 6.45M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | -961.11K | 1.10M | -72K | -151.14K |
Cash used in financing activities | 6.47M | 1.22M | 611.22K | 277.35K |
Net Change In Cash | 1.87M | 149.46K | -76.30K | -95.17K |
Cash at end of period | 2.14M | 264.86K | 115.39K | 191.70K |
| Data source |